SPOTLIGHT -
California Startup Exploring Novel ALS Discovery Platform
A grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.